Critical Path Institute, Limited

Where the EU money came from

Funding by EU programme. Amounts are Critical Path Institute, Limited's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• UNITE4TBPartner

  ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS

  Horizon 2020 · 2021–2028 · Project on CORDIS ↗

  €2.4Mtheir share
• ERA4TBPartner

  EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  €1.7Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Uppsala UniversitetSweden · 2 shared projects
• Forschungszentrum Borstel Leibniz LungenzentrumGermany · 2 shared projects
• Janssen Pharmaceutica NVBelgium · 2 shared projects
• Glaxosmithkline Investigacion y Desarrollo SLSpain · 2 shared projects
• Global Alliance for Tb Drug Development Non Profit OrganisationUnited States · 2 shared projects
• Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 1 shared project
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
• Consiglio Nazionale Delle RicercheItaly · 1 shared project
• Ecole Polytechnique Federale de LausanneSwitzerland · 1 shared project
• University College LondonUnited Kingdom · 1 shared project
• Ludwig-Maximilians-Universitaet MuenchenGermany · 1 shared project
• Lunds UniversitetSweden · 1 shared project
• Universita Degli Studi di PadovaItaly · 1 shared project
• Institut PasteurFrance · 1 shared project
• Universita Degli Studi di MilanoItaly · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• artificial intelligence
• diabetes
• drug discovery
• drug resistance
• microbiology
• primatology
• simulation software
• tuberculosis